MyAverix Finance
US · Healthcare
Stemtech Corporation (STEK)
Drug Manufacturers - Specialty & Generic
Stemtech Corporation (STEK) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for STEK
Stemtech Corporation (STEK) — FAQ
What is STEK's P/E ratio?
The price-to-earnings (P/E) ratio for Stemtech Corporation (STEK) is 18.00 (data as of 2026-05-23).
Does Stemtech Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Stemtech Corporation (STEK). Check the MyAverix Finance app for the latest dividend data.
What sector is Stemtech Corporation in?
Stemtech Corporation (STEK) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is STEK listed on?
STEK is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.